Skip to content
Clinical Trials – home

Uniwersytecki Szpital Kliniczny W Opolu

Research site

Poland Al. Wincentego Witosa 26, 45-401 Opole, Poland

  • 24 trials recruiting
  • Chronic spontaneous urticaria · Acute coronary syndrome · Acute myocardial infarction
  • Adults and children

About Specializations

Uniwersytecki Szpital Kliniczny W Opolu in Opole, Poland specialises in clinical trials of conditions such as Chronic spontaneous urticaria, Acute coronary syndrome, Acute myocardial infarction, Type 2 diabetes mellitus, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases

At Uniwersytecki Szpital Kliniczny W Opolu, clinical research in cardiovascular diseases focuses on serious heart conditions such as acute myocardial infarction and cardiogenic shock. The studies are designed to assess whether new treatments can improve blood pressure, support heart recovery, and enhance care after a heart attack.

  • Evaluating a potential therapy for acute myocardial infarction
  • Testing treatment options for cardiogenic shock
  • Assessing safety, tolerability, and treatment effectiveness in acute cardiac care

This work reflects a strong focus on urgent cardiology needs, with the goal of improving outcomes for patients facing life-threatening heart-related events.

Skin and Connective Tissue Diseases

Research in skin and connective tissue diseases at this site includes studies in chronic spontaneous urticaria, a condition that can cause persistent itching and hives. The trials are aimed at evaluating new therapies that may help control symptoms and improve daily comfort for affected adults.

  • Studying treatment options for chronic spontaneous urticaria
  • Assessing symptom relief and overall effectiveness of a new therapy
  • Exploring better ways to manage long-term allergic skin disease

This area highlights the hospital’s broader interest in both dermatologic and inflammatory conditions, with research centered on improving patient well-being through more effective care.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Al. Wincentego Witosa 2645-401 OpolePoland
Recruiting now
24 trials
Conditions studied
37

More sites in OpolePoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

45 clinical trials

Cold urticaria

Recruiting

A study to evaluate the effectiveness of barzolvolimab in participants with cold urticaria and symptomatic dermographism

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.

A study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study on Rituximab for Adults with Relapsing Steroid-Sensitive Nephrotic Syndrome

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Medical University Of Lodz

Study on the Effects of Ferric Carboxymaltose on Heart Health and Quality of Life in Patients with Recent Heart Attack and Iron Deficiency

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Agencja Badań Medycznych

Iron deficiency

Recruiting

Effect of Ferric Carboxymaltose, Ferrous Sulfate, and Sodium Chloride vs Placebo on Physical Performance in Frail Elderly with Iron Deficiency and Cardiovascular Disease

Registered drug
Countries:PolandPoland
  • Participants:65+ years
  • Substances:Sodium Chloride
  • Sponsor:Wroclaw Medical University

VMX-C001 in Patients Taking Factor Xa Inhibitors Who Need Urgent Surgery or an Invasive Procedure With High Bleeding Risk

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:VMX-C001
  • Sponsor:VarmX B.V.

A study on the effectiveness of cagrilintide and semaglutide for weight management in children and adolescents with obesity

Investigational
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

A study to evaluate the efficacy and safety of lesigercept in adults with chronic spontaneous urticaria who do not have enough relief from antihistamines

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Yuhan Corp.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Zigakibart
  • Sponsor:Novartis Pharma AG

Dyslipidaemia+1

Recruiting

Study of the efficacy and safety of inclisiran and a drug combination in patients with acute coronary syndrome

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Sodium Chloride
  • Sponsor:Sab Biotherapeutics Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.